Study AER-01-002 is using a novel and precision imaging strategy to enroll 100 mucus plug-high chronic obstructive pulmonary ... lung function and symptoms in COPD patients with moderate to ...

New Study Shows Promising Results ... and Improves Lung Function Aug. 21, 2024 — In preclinical models, the inhalation of a mixture of living Lactobacilli bacteria attenuated pulmonary ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary ... for people with COPD in the ENHANCE-2 study, cutting the rate of moderate to severe ...

Also assessed were effects on interleukin (IL)-8 levels, lung function and symptoms. Results: Both NAC 600 and ... by standard clinical and laboratory tests.

Image Credit: Sophon Nawit/Shutterstock.com In a recent article in Chronic Obstructive Pulmonary Diseases ... period has been linked to reduced lung function and increased COPD risk later in ...

A markedly enlarged alveolar-arterial oxygen gradient (44 mmHg) coexisted with moderate to severe hypoxemia (PaO ... of end-stage liver disease and their impact on common pulmonary function test ...

The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary ... in eight of nine lung function goals in patients with moderate to severe COPD.

Black Americans have a higher likelihood of having asthma-COPD overlap syndrome (ACOS) but may not know it. Here’s what you ...

for PAH Winrevair was greenlit March 26 for treating adults with pulmonary arterial hypertension (PAH), based on compelling results from the Phase 3 STELLAR trial, which showed the treatment led to ...

results. Objective: This study aims to evaluate the diagnostic value of various lung function tests in patients with long-term COVID-19, explicitly focusing on positive BPT outcomes. Methods: Our ...

Background Hypoxic pulmonary vasoconstriction leads to an increase in pulmonary artery pressure (PAP) and potentially right ...